Sign In
Buy RHHBY
$51.57
+2.51 (+5.12%)
At Close: Jun 04, 2026
RHHBY or ABBV: Which Is the Better Value Stock Right Now?
12:40pm, Thursday, 07'th Nov 2024
Investors looking for stocks in the Large Cap Pharmaceuticals sector might want to consider either Roche Holding AG (RHHBY) or AbbVie (ABBV). But which of these two stocks offers value investors a bet
Genentech to Present New and Encouraging Long-term Follow-up Data Across Broad Hematology Portfolio at ASH 2024
09:15am, Tuesday, 05'th Nov 2024
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorder
Roche to present new and encouraging long-term follow-up data across broad haematology portfolio at ASH 2024
09:15am, Tuesday, 05'th Nov 2024
Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) An
PredicineCARE™ Liquid Biopsy Assay Featured in NEJM as Pivotal Tool in Roche's Phase III Itovebi Breast Cancer Trial
12:28pm, Monday, 04'th Nov 2024
PredicineCARE™ was utilized to identify and enroll patients with PIK3CA-mutated metastatic breast cancer in China, a key component contributing to the FDA's approval of Inavolisib in the U.S. on Oct
Dublin, Nov. 04, 2024 (GLOBE NEWSWIRE) -- The "Antibody-Drug Conjugates: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.
Roche Holding AG (RHHBY) Virtual Neurology Investor Event Conference Transcript
02:53am, Saturday, 02'nd Nov 2024
Roche Holding AG (OTCQX:RHHBY) Virtual Neurology Investor Event Conference October 31, 2024 11:00 AM ET Company Participants Bruno Eschli – Investor Relations Azad Bonni – Senior Vice President an
Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer's disease
02:15am, Thursday, 31'st Oct 2024
Basel, 31 October 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new late-breaking data on its Elecsys Amyloid Plasma Panel (combination of pTau181 and ApoE4) , for Alzheimer's disease, at
Basel, 31 October 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that a detailed analysis of the positive phase III INAVO120 results, evaluating ItovebiTM (inavolisib) in combination with p
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that a detailed analysis of the positive Phase III INAVO120 results,
'We'll see a period of haggling' over coalitions in Japan: David Roche
11:15am, Monday, 28'th Oct 2024
David Roche, strategist at Quantum Strategy, discusses the recent elections in Japan and its potential impact on markets.
Roche: Currency Headwinds Are Masking Strong Growth Trends
09:35pm, Sunday, 27'th Oct 2024
Roche's strong year-to-date results are masked by the strength of the Swiss franc and are also impacted by declining COVID-19 sales, but underlying growth trends are strong. Key products like Vabysmo,
Roche CEO says there is strong underlying growth in our business
08:30am, Thursday, 24'th Oct 2024
Roche CEO Thomas Schinecker joins Squawk Box after the pharma group's third-quarter sales rose 9%.
Roche Holding AG (RHHBY) Q3 2024 Sales/Trading Statement Call
02:18pm, Wednesday, 23'rd Oct 2024
Roche Holding AG (RHHBY) Q3 2024 Sales/Trading Statement Call
Vabysmo, Hemlibra Drive Roches Sales in Q3 & First 9 Months of 2024
10:15am, Wednesday, 23'rd Oct 2024
RHHBY records impressive sales growth in Q3 and the first nine months of 2024 on the back of strong demand for Vabysmo, Hemlibra and Ocrevus.
Roche comes out against clearing takeover of drug manufacturer Catalent
04:41am, Wednesday, 23'rd Oct 2024
The CEO of pharmaceuticals giant Roche has urged authorities to block the takeover of contract drug manufacturer Catalent by Novo Nordisk's controlling shareholder, citing harm to industry peers.
